AIM: Improved survival after cardiac arrest has placed greater emphasis on neurologic resuscitation. The purpose of this pilot study was to evaluate the relationship between cerebrovascular autoregulation and neurologic outcomes after pediatric cardiac arrest. METHODS: Children resuscitated from cardiac arrest had autoregulation monitoring during the first 72h after return of circulation with an index derived from near-infrared spectroscopy in a pilot study. The range of mean arterial blood pressure (MAP) with optimal vasoreactivity (MAPOPT) was identified. The area under the curve (AUC) of the time spent with MAP below MAPOPT and MAP deviation below MAPOPT was calculated. Neurologic outcome measures included placement of a new tracheostomy or gastrostomy, death from a primary neurologic etiology (brain death or withdrawal of support for neurologic futility), and change in the Pediatric Cerebral Performance Category score (ΔPCPC). RESULTS: Thirty-six children were monitored. Among children who did not require extracorporeal membrane oxygenation (ECMO), children who received a tracheostomy/gastrostomy had greater AUC during the second 24h after resuscitation than those who did not (P=0.04; n=19). Children without ECMO who died from a neurologic etiology had greater AUC during the first 48h than did those who lived or died from cardiovascular failure (P=0.04; n=19). AUC below MAPOPT was not associated with ΔPCPC when children with or without ECMO were analyzed separately. CONCLUSIONS: Deviation from the blood pressure with optimal autoregulatory vasoreactivity may predict poor neurologic outcomes after pediatric cardiac arrest. This experimental autoregulation monitoring technique may help individualize blood pressure management goals after resuscitation.
AIM: Improved survival after cardiac arrest has placed greater emphasis on neurologic resuscitation. The purpose of this pilot study was to evaluate the relationship between cerebrovascular autoregulation and neurologic outcomes after pediatric cardiac arrest. METHODS:Children resuscitated from cardiac arrest had autoregulation monitoring during the first 72h after return of circulation with an index derived from near-infrared spectroscopy in a pilot study. The range of mean arterial blood pressure (MAP) with optimal vasoreactivity (MAPOPT) was identified. The area under the curve (AUC) of the time spent with MAP below MAPOPT and MAP deviation below MAPOPT was calculated. Neurologic outcome measures included placement of a new tracheostomy or gastrostomy, death from a primary neurologic etiology (brain death or withdrawal of support for neurologic futility), and change in the Pediatric Cerebral Performance Category score (ΔPCPC). RESULTS: Thirty-six children were monitored. Among children who did not require extracorporeal membrane oxygenation (ECMO), children who received a tracheostomy/gastrostomy had greater AUC during the second 24h after resuscitation than those who did not (P=0.04; n=19). Children without ECMO who died from a neurologic etiology had greater AUC during the first 48h than did those who lived or died from cardiovascular failure (P=0.04; n=19). AUC below MAPOPT was not associated with ΔPCPC when children with or without ECMO were analyzed separately. CONCLUSIONS: Deviation from the blood pressure with optimal autoregulatory vasoreactivity may predict poor neurologic outcomes after pediatric cardiac arrest. This experimental autoregulation monitoring technique may help individualize blood pressure management goals after resuscitation.
Authors: Jennifer K Lee; Zeng-Jin Yang; Bing Wang; Abby C Larson; Jessica L Jamrogowicz; Ewa Kulikowicz; Kathleen K Kibler; Jennifer O Mytar; Erin L Carter; Hillary T Burman; Ken M Brady; Peter Smielewski; Marek Czosnyka; Raymond C Koehler; Donald H Shaffner Journal: Anesth Analg Date: 2012-02-07 Impact factor: 5.108
Authors: Seetha Shankaran; Abbot R Laptook; Scott A McDonald; Rosemary D Higgins; Jon E Tyson; Richard A Ehrenkranz; Abhik Das; Guilherme Sant'Anna; Ronald N Goldberg; Rebecca Bara; Michele C Walsh Journal: Pediatr Crit Care Med Date: 2012-01 Impact factor: 3.624
Authors: Jennifer K Lee; Kathleen K Kibler; Paul B Benni; R Blaine Easley; Marek Czosnyka; Peter Smielewski; Raymond C Koehler; Donald H Shaffner; Ken M Brady Journal: Stroke Date: 2009-03-12 Impact factor: 7.914
Authors: R Blaine Easley; Kathleen K Kibler; Kenneth M Brady; Brijen Joshi; Masahiro Ono; Charles Brown; Charles W Hogue Journal: Neurol Res Date: 2013-05 Impact factor: 2.448
Authors: J M Pollock; A R Deibler; C T Whitlow; H Tan; R A Kraft; J H Burdette; J A Maldjian Journal: AJNR Am J Neuroradiol Date: 2008-10-14 Impact factor: 3.825
Authors: Yoshikazu Kusano; German Echeverry; Greg Miekisiak; Tobias B Kulik; Shimon N Aronhime; Jiang F Chen; H Richard Winn Journal: J Cereb Blood Flow Metab Date: 2009-11-18 Impact factor: 6.200
Authors: Lance R Hoover; Radhika Dinavahi; Wei-Ping Cheng; John R Cooper; Maria Rosa Marino; Tyler C Spata; Gaile L Daniels; William K Vaughn; Nancy A Nussmeier Journal: Anesth Analg Date: 2009-05 Impact factor: 5.108
Authors: Melisa Carrasco; Jamie Perin; Jacky M Jennings; Charlamaine Parkinson; Maureen M Gilmore; Raul Chavez-Valdez; An N Massaro; Raymond C Koehler; Frances J Northington; Aylin Tekes; Jennifer K Lee Journal: Pediatr Neurol Date: 2018-04-02 Impact factor: 3.372
Authors: Christopher J Rhee; Cristine Sortica da Costa; Topun Austin; Ken M Brady; Marek Czosnyka; Jennifer K Lee Journal: Pediatr Res Date: 2018-09-08 Impact factor: 3.756
Authors: Jennifer K Lee; Andrea Poretti; Jamie Perin; Thierry A G M Huisman; Charlamaine Parkinson; Raul Chavez-Valdez; Matthew O'Connor; Michael Reyes; Jillian Armstrong; Jacky M Jennings; Maureen M Gilmore; Raymond C Koehler; Frances J Northington; Aylin Tekes Journal: Dev Neurosci Date: 2016-12-16 Impact factor: 2.984
Authors: Jennifer C Laws; Lori C Jordan; Lindsay M Pagano; John C Wellons; Michael S Wolf Journal: Pediatr Neurol Date: 2022-02-02 Impact factor: 3.372